Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period.

Current clinical pharmacology

Volumn 1, Issue 1, 2006, Pages 103-108

  Voulgari, Paraskevi V ^a   Alamanos, Yannis ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DRUG ANTAGONISM; DRUG COMBINATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMANS; MAGNETIC RESONANCE IMAGING; METHOTREXATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49049090188     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488406775268264     Document Type: Article

References (0)